These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 23436997)
1. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. Skalska L; White RE; Franz M; Ruhmann M; Allday MJ PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Maruo S; Zhao B; Johannsen E; Kieff E; Zou J; Takada K Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1919-24. PubMed ID: 21245331 [TBL] [Abstract][Full Text] [Related]
4. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416 [TBL] [Abstract][Full Text] [Related]
7. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. Ohashi M; Holthaus AM; Calderwood MA; Lai CY; Krastins B; Sarracino D; Johannsen E PLoS Pathog; 2015 Apr; 11(4):e1004822. PubMed ID: 25855980 [TBL] [Abstract][Full Text] [Related]
8. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Maruo S; Wu Y; Ishikawa S; Kanda T; Iwakiri D; Takada K Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19500-5. PubMed ID: 17159137 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes. Ohashi M; Hayes M; McChesney K; Johannsen E PLoS Pathog; 2021 Mar; 17(3):e1009419. PubMed ID: 33720992 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the Bazot Q; Paschos K; Allday MJ J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247 [TBL] [Abstract][Full Text] [Related]
12. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation. Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822 [TBL] [Abstract][Full Text] [Related]
13. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051 [TBL] [Abstract][Full Text] [Related]
14. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model. Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC J Virol; 2020 May; 94(10):. PubMed ID: 32132242 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites. Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268 [TBL] [Abstract][Full Text] [Related]
16. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782 [TBL] [Abstract][Full Text] [Related]
17. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6. Sun K; Bose D; Singh RK; Pei Y; Robertson ES J Virol; 2024 Jul; 98(7):e0054824. PubMed ID: 38864622 [TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells. Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Maruo S; Wu Y; Ito T; Kanda T; Kieff ED; Takada K Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4419-24. PubMed ID: 19237563 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. Bazot Q; Paschos K; Skalska L; Kalchschmidt JS; Parker GA; Allday MJ PLoS Pathog; 2015 Jul; 11(7):e1005031. PubMed ID: 26153983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]